IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness. (7th November 2013) - Johnson, C Bryce; May, Bennett R; Cloud, Colleen A; Rubinstein, Mark P; Cole, David J